Hardy Alexander bought BMRN
March 16, 2026 · Form 4 insider transaction
Hardy Alexander bought 89,200 shares of BioMarin Pharmaceutical Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
89,200
Price
$0.00
Total value
N/A
InsiderHardy Alexander
Role—
SecurityStock Option (Right to Buy Common Stock)
Transaction codeA: Grant or award
Transaction dateMarch 16, 2026
Filing dateMarch 17, 2026
Shares owned after89,200
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Option grant vests 12/48th on March 16, 2027 and 1/48th on the 16th day of each month thereafter.